Clinical Analysis of Kawasaki Disease Shock Syndrome.
作者信息
Zhang Ming-Ming, Shi Lin, Li Xiao-Hui, Lin Yao, Liu Yang
机构信息
Department of Cardiology, Children's Hospital Affiliated to the Capital Institute of Pediatrics, Beijing 100020, China.
出版信息
Chin Med J (Engl). 2017 Dec 5;130(23):2891-2892. doi: 10.4103/0366-6999.219151.
Abstract
摘要
相似文献
1
Clinical Analysis of Kawasaki Disease Shock Syndrome.川崎病休克综合征的临床分析
Chin Med J (Engl). 2017 Dec 5;130(23):2891-2892. doi: 10.4103/0366-6999.219151.
2
[Shock as initial presentation of Kawasaki disease].[以休克为初始表现的川崎病]
An Pediatr (Barc). 2009 Oct;71(4):372-4. doi: 10.1016/j.anpedi.2009.06.022. Epub 2009 Sep 9.
3
Kawasaki disease shock syndrome: Case report and cytokine profiling.川崎病休克综合征：病例报告及细胞因子分析
Pediatr Int. 2019 Jun;61(6):620-622. doi: 10.1111/ped.13864. Epub 2019 Jun 19.
4
Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.川崎病休克综合征：川崎病的独特且严重的亚型。
Pediatr Int. 2018 Sep;60(9):781-790. doi: 10.1111/ped.13614.
5
Hypotension in a Febrile Child-Beware of Kawasaki Disease Shock Syndrome.发热儿童的低血压——警惕川崎病休克综合征
J Clin Rheumatol. 2020 Aug;26(5):e130-e131. doi: 10.1097/RHU.0000000000001002.
6
Fatal Myocardial Ischemic Shock after Kawasaki Disease, the Not to Be Missed Differential Diagnosis.川崎病后致命性心肌缺血性休克，不容忽视的鉴别诊断。
Prehosp Emerg Care. 2021 Mar-Apr;25(2):314-315. doi: 10.1080/10903127.2020.1828519. Epub 2020 Oct 19.
7
What dose of intravenous immunoglobulin should be administered in Kawasaki disease with suspected systemic capillary leak syndrome? Comment on: shock: an unusual presentation of Kawasaki disease (Eur J Pediatr. 2011 Jul; 170(7):941-3).对于疑似全身性毛细血管渗漏综合征的川崎病患者，应给予何种剂量的静脉注射免疫球蛋白？评论：休克：川崎病的一种不寻常表现（《欧洲儿科学杂志》。2011年7月；170(7):941 - 3）
Eur J Pediatr. 2012 Jan;171(1):203-4; author reply 205. doi: 10.1007/s00431-011-1602-7. Epub 2011 Oct 27.
8
[A case of adolescent Kawasaki disease with coronary artery aneurysm, shock and multi-organ dysfunction].一例伴有冠状动脉瘤、休克及多器官功能障碍的青少年川崎病
Zhonghua Er Ke Za Zhi. 2006 Dec;44(12):917.
9
Hyponatremia Is a Feature of Kawasaki Disease Shock Syndrome: A Case-Control Study.低钠血症是川崎病休克综合征的特征：一项病例对照研究。
J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):386-388. doi: 10.1093/jpids/piw081.
10
Cardiogenic shock: do not forget the possibility of Kawasaki disease.心源性休克：不要忽视川崎病的可能性。
Turk J Pediatr. 2012 Jan-Feb;54(1):86-9.
引用本文的文献
1
Impact of time to diagnosis on the occurrence of cardiogenic shock in MIS-C post-COVID-19 infection.COVID-19 感染后 MIS-C 中诊断时间对心源性休克发生的影响。
World J Pediatr. 2023 Jun;19(6):595-604. doi: 10.1007/s12519-022-00681-8. Epub 2023 Jan 6.
2
[Clinical details in the diagnosis of Kawasaki disease].[川崎病诊断中的临床细节]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Dec 15;24(12):1307-1310. doi: 10.7499/j.issn.1008-8830.2208124.
3
A global review of racial, ethnic and socio-economic disparities in multisystem inflammatory syndrome in children related to COVID-19.一项关于与 COVID-19 相关的儿童多系统炎症综合征中种族、民族和社会经济差异的全球综述。
Front Public Health. 2022 Oct 20;10:996311. doi: 10.3389/fpubh.2022.996311. eCollection 2022.
4
MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染相关的儿童多系统炎症综合征（MIS-C）：临床表现、鉴别诊断及管理的叙述性综述
Infez Med. 2022 Sep 1;30(3):344-352. doi: 10.53854/liim-3003-3. eCollection 2022.
5
Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review.儿童川崎病合并急性呼吸窘迫综合征 1 例报告并文献复习
BMC Pulm Med. 2022 Jun 6;22(1):220. doi: 10.1186/s12890-022-02007-w.
6
Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.新冠病毒病中免疫失调的机制不同于非典和中东呼吸综合征：从川崎病和儿童多系统炎症综合征角度的探讨
Front Pediatr. 2022 May 5;10:790273. doi: 10.3389/fped.2022.790273. eCollection 2022.
7
Multisystem Inflammatory Syndrome in Children: Examining Emerging Data and Identifying Key Knowledge Gaps.儿童多系统炎症综合征：探讨新出现的数据并确定关键知识空白。
Pediatr Emerg Care. 2022 Feb 1;38(2):83-91. doi: 10.1097/PEC.0000000000002633.
8
Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis.川崎病休克综合征患儿的临床特征：系统评价与荟萃分析
Front Cardiovasc Med. 2021 Sep 21;8:736352. doi: 10.3389/fcvm.2021.736352. eCollection 2021.
9
Pediatric Rheumatologic Effects of COVID-19.儿童 COVID-19 相关风湿免疫效应。
Pediatr Clin North Am. 2021 Oct;68(5):1011-1027. doi: 10.1016/j.pcl.2021.05.002.
10
Kawasaki Disease Shock Syndrome in the Eastern Region of Saudi Arabia: Case Series.沙特阿拉伯东部地区的川崎病休克综合征：病例系列
Cureus. 2021 May 11;13(5):e14961. doi: 10.7759/cureus.14961.
本文引用的文献
1
Management of Kawasaki disease.川崎病的治疗。
Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841. Epub 2013 Oct 25.
2
Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.川崎病休克综合征的临床表现：一项病例对照研究。
J Microbiol Immunol Infect. 2015 Feb;48(1):43-50. doi: 10.1016/j.jmii.2013.06.005. Epub 2013 Aug 6.
3
Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.与墨西哥儿童川崎病休克综合征相关的临床表现。
Eur J Pediatr. 2013 Mar;172(3):337-42. doi: 10.1007/s00431-012-1879-1. Epub 2012 Nov 15.
4
Recognition of a Kawasaki disease shock syndrome.川崎病休克综合征的识别。
Pediatrics. 2009 May;123(5):e783-9. doi: 10.1542/peds.2008-1871.
5
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理：美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会为卫生专业人员发布的声明
Pediatrics. 2004 Dec;114(6):1708-33. doi: 10.1542/peds.2004-2182.
Zotero 插件